Yabao Pharmaceutical Group   Report issue

For profit Phase 1 Phase 2
Founded: Beijing China (1978)
Status: No NME R&D (1978)

Organization Overview

First Clinical Trial
2015
NCT02599337
First Marketed Drug
2006
meloxicam (mobic)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Suzhou Yabao Pharmaceutical R&D Co., Ltd. | YABAO PHARM | Yabao Pharmaceutical Group | Yabao pharmaceutical Group Co.